Study finds pain gene affects success of chronic pain medicine in women
Chronic pelvic pain is a disabling condition that affects around one in four women worldwide
Read MoreChronic pelvic pain is a disabling condition that affects around one in four women worldwide
Read MoreLT-HSCs replenish blood cells after treatment for blood cancers, such as leukaemia
Read MoreThe most commonly diagnosed cancer in men in the UK leads to over 12,000 annual deaths
Read MoreGenentech’s Pulmozyme could also treat other respiratory infections and conditions
Read MoreThe new technology can generate a target infection within 30 minutes to two hours
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
